Clinical Trial Update: PPIO-006 Primary Tumor Resection for IVa NSCLC

View source ↗

Summary

A clinical trial update confirms the completion of NCT06232967, evaluating primary tumor resection for stage IVa non-small cell lung cancer, sponsored by Daping…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Conditions: Non-small-cell Lung Cancer (NSCLC) | Status: COMPLETED